AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
MO-201, a candidate therapeutic for drug-resistant Cancer Stem Cells
Detailed Technology Description
This invention comprises novel compounds of the Glycosylated Antitumor Ether Lipid (GAEL) class, which selectively target apoptosis-resistant cancer stem cells in ovarian cancer and breast cancer.
Country/Region
USA
For more information, please click Here